Kevin C. Coleman - Vice President-Investor Relations Frank S. Hermance - Chairman & Chief Executive Officer Robert R. Mandos - Chief Financial Officer & Executive Vice President David A. Zapico - Chief Operating Officer & Executive Vice President.

Allison A. Poliniak-Cusic - Wells Fargo Securities LLC Mike W. Sang - Morgan Stanley & Co. LLC Christopher D. Glynn - Oppenheimer & Co., Inc. (Broker) Matthew McConnell - RBC Capital Markets LLC Robert Paul McCarthy - Stifel, Nicolaus & Co., Inc. R. Scott Graham - Jefferies LLC Joe K. Radigan - KeyBanc Capital Markets, Inc.

Mark Douglass - Longbow Research LLC Richard Eastman - Robert W. Baird & Co., Inc. (Broker).

Ladies and gentlemen, thank you for standing by. Welcome to the AMETEK First Quarter 2015 Earnings Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. As a reminder, this conference is being recorded, Wednesday, April 29, 2015.

I would now like to turn the conference over to Kevin Coleman, Vice President, Investor Relations. Please go ahead, sir..

Great. Thank you, Susie. Good morning, everyone. Welcome to AMETEK's first quarter earnings conference call. Joining me this morning are Frank Hermance, Chairman and CEO; Bob Mandos, Executive Vice President and Chief Financial Officer; and David Zapico, Executive Vice President and Chief Operating Officer.

AMETEK's first quarter results were released earlier this morning. These results are available electronically on market systems and our website at the Investor section of ametek.com. A tape of today's call may be accessed until May 13 by calling 800-633-8284 and entering the confirmation code 21766195. This call is also webcasted.

It can be accessed ametek.com and streetevents.com. The call will be archived on both of these sites. I will remind you that any statements made by AMETEK during the call that are not historical in nature are to be considered forward-looking statements.

As such, these statements are subject to change based on various risk factors and uncertainties that may cause actual results to differ significantly from expectations. A detailed discussion of the risk and uncertainties that may affect our future results is contained in AMETEK's filings with the Securities and Exchange Commission.

AMETEK disclaims any intention or obligation to update or revise any forward-looking statements. I will also refer you to the Investor section of ametek.com for a reconciliation of any non-GAAP financial measures used during this conference call. We will begin today with prepared remarks and then we'll open it up for questions.

I'll now turn the meeting over to Frank..

Thank you, Kevin, and good morning, everyone. AMETEK had a very good start to 2015, with double-digit earnings growth and excellent operating performance. Since we were seeing the effects of a continued strong U.S. dollar and a sluggish global economy, we proactively took actions in the first quarter to mitigate these effects.

These actions position us to deliver earnings in line with our initial guidance. The realignment costs in the quarter totaled $15.9 million or approximately $0.04 per diluted share. The savings resulting from this realignment is about $40 million in 2015 and $55 million on an annualized basis.

We were very selective in these actions so our future growth will not be impacted. All financial results and commentary on the call today will be on an adjusted basis, excluding this realignment costs. Now on to the financial results. In the first quarter, sales increased 1% to $984.1 million.

Organic growth was also up 1%, while acquisitions added 4% and foreign currency was a larger-than-anticipated 4% headwind in the quarter. Operating income for the first quarter increased 7% to a record $236.9 million. Operating income margin in the quarter was superb at a record of 24.1%, a 140-basis-point improvement over the first quarter of 2014.

Net income was up 9% to $152.9 million, and diluted earnings per share of $0.63 were up 11% over last year's first quarter and at the high end of our guidance range. Operating working capital was 18.2% of sales in the quarter. Now turning to the individual operating groups. The Electronic Instruments Group had a very good first quarter.

For the quarter, sales were up 4% to $593.8 million, driven by solid organic growth in our Aerospace, Power and Industrial businesses, plus the contributions from the recent acquisitions of Zygo and AMPTEK. Internal growth was flat, while acquisitions added 7% and foreign currency was a 3% headwind.

EIG's operating income increased 7% to $160.5 million, and operating margins were 27% in the quarter, up 70 basis points from last year's first quarter. The Electromechanical Group also performed extremely well in the quarter. Overall sales were down 3% to $390.3 million. As a result of a 5% foreign currency headwind, organic sales were up 2%.

EMG's operating income increased 6% to $88.5 million, and operating margins were superb at a record 22.7% in the quarter, up 190 basis points from the previous year. Now turning to our four growth strategies of Operational Excellence, Global & Market Expansion, New Product Development and Strategic Acquisitions.

The solid and balanced execution of these growth strategies by our employees is the principal reason for our ongoing success. Each of these strategies will continue to play a key role in driving our growth. First, I will touch on Operational Excellence. Operational Excellence is the cornerstone strategy for AMETEK.

We continue to focus on operational improvements to help drive both our competitive and financial success. Our results this quarter reflect the tremendous impact of our Operational Excellence initiatives, as we were able to expand operating margins 140 basis points to a record 24.1%.

Our management teams and employees continue to do an excellent job driving continual operational improvements and efficiencies through their businesses by leveraging the Operational Excellence tools we have put in place throughout the company.

One such initiative is our global sourcing and strategic procurement activities, where we continue to deliver exceptional results. For all of 2015, we anticipate approximately $70 million in savings from our global sourcing and strategic procurement initiatives.

Overall, we now anticipate approximately $145 million of total Operational Excellence savings in 2015, up from our initial estimate of $105 million of total savings. This $40 million increase in Operational Excellence savings is driven by the realignment actions we started in the first quarter. Now moving to New Products.

New product development is a key internal growth driver and critical to our long-term health and growth. We have consistently increased our investment in RD&E to ensure our businesses are developing the right products to serve our customers and markets. In 2015, we expect to spend about $210 million on RD&E or approximately 5% of total sales.

We're excited about some recent new product introductions. The new Talysurf i-Series surface and contour measurement tool from our Taylor Hobson business has been very well received since its recent launch. This high-resolution device offers automated, simultaneous surface and contour inspection.

It features powerful software capabilities for the analysis of surface finish and form and a unique temperature compensation system that ensures consistent performance, regardless of the operating environment. Our TMC business recently introduced their latest new product, the Stage-Base 450.

This product represents the latest generation of vibration and motion cancellation technology from TMC. The Stage-Base 450 was designed specifically to be the primary vibration cancellation system for high-precision semiconductor tools, an attractive high-growth market.

It incorporates technical advances to compensate for building floor vibration while increasing semiconductor wafer processing throughput.

Lastly, our Electronic Components and Packaging business, a leading provider of electronic and electromechanical packages for harsh environment applications, unveiled its most recent design breakthrough for microelectronic packaging. This design is a patent-pending S-Bend Feedthrough that provides high fidelity for radio frequency signals.

The innovative design satisfies the need for higher frequencies and greater bandwidth in optical communications, with capability greater than 80 gigahertz. The market feedback on this new design has been very strong.

From an overall perspective, revenue from products introduced over the last three years was strong at 22% of sales in the quarter, and that's up from 20% of sales in last year's first quarter. Now turning to Global & Market Expansion.

Global & Market Expansion remains an important part of our long-term growth as we look to expand our presence in attractive, higher-growth market segments and geographies.

We are making investments globally to develop and expand our sales channels, service capabilities and manufacturing footprint in order to position our businesses to capitalize on the attractive growth opportunities in these international markets.

International sales represent 52% of our total sales in the quarter, and we continue to see strong growth in China, where first quarter organic growth was up mid-teens.

Also, as part of our acquisition integration process, we identify opportunities for acquired businesses to leverage AMETEK's global infrastructure to help them quickly and efficiently expand globally. Acquired businesses have had tremendous success in expanding their global manufacturing, sales and service capabilities to penetrate new markets.

One recent example is AMPTEK, which we acquired last August. AMPTEK is opening up a new service center in our ASUS (11:24) facility in Shanghai. This expanded capability has already led to three large orders for their x-ray fluorescent detectors from Chinese OEMs. Lastly, let me touch on Acquisitions.

Over the last 21 months, we have completed eight acquisitions, deployed nearly $1 billion in capital and acquired approximately $460 million in sales. Acquisitions will continue to be a key focus for us during 2015, as we see this strategy as a key driver for the creation of shareholder value. It remains the primary focus of our strong cash flow.

Our pipeline remains strong. We have the managerial and financial capacity and disciplined approach to support this acquisition focus. Our balance sheet, cash flow, and financing facilities provide us with ample liquidity to pursue this strategy.

We will continue to capitalize on our strong core competency of acquiring and integrating high-quality businesses that allows us to expand our presence in attractive market segments. Turning to the outlook now for 2015. As a result of the strength of the U.S.

dollar and a continued slow macro growth environment, we now anticipate overall 2015 revenue to be down slightly on a percentage basis from 2014. We expect organic growth to increase low single digits on a percentage basis, which is at the low end of our initial guidance range. Currency is expected to be approximately a 4% headwind.

We continue to expect earnings for 2015 to be in the range of $2.58 to $2.63 per diluted share, up 7% to 9% over last year's adjusted earnings per share. Overall second quarter 2015 sales are expected to be flat versus the second quarter of 2014.

We expect our earnings to be approximately $0.63 to $0.64 per diluted share in the quarter, up 3% to 5% over last year's second quarter. Our solid backlog, strong portfolio of businesses, proven Operational Excellence capability and a successful focus on strategic acquisitions should enable us to perform well in 2015.

So in summary, I'm very pleased with our overall performance in the first quarter. Despite a number of macro headwinds, we are very confident in our ability to execute our growth strategies and continue to deliver strong earnings growth. Bob will now cover some of the financial details, and then we'll be very glad to answer your questions.

Bob?.

Thank you, Frank. As Frank noted, we had a good first quarter, with very strong operating performance. I'll provide some further details. In the quarter, selling expenses were down slightly versus last year's first quarter. General and administrative expenses were 1.2% of sales in the quarter, down from last year's first quarter level of 1.3%.

The effective tax rate for the quarter was 28.1%, down from last year's first quarter rate of 29.3% and in line with our expectations. The lower tax rate in the quarter was the result of an ongoing international tax planning activities. For 2015, we estimate our tax rate to be between 28% and 29%.

As we have said before, actual quarterly tax rates can differ dramatically, either positively or negatively from this full-year rate. On the balance sheet, working capital, defined as receivables plus inventory less payables, was 18.2% of sales in the first quarter. Strong working capital management remains a key priority.

Capital expenditures were $14 million for the quarter. The full-year 2015 capital expenditures are expected to be approximately $75 million. Depreciation and amortization was $35 million for the quarter. 2015 depreciation and amortization is expected to be approximately $145 million. In the first quarter, we made a $50 million contribution to our U.S.

defined benefit pension plan to offset lower discount rates and a change in the mortality tables. Excluding this contribution, operating cash flow was $172 million in the quarter, up 7% over last year's first quarter. And free cash flow was $158 million or 111% of net income.

For the full year, we expect free cash flow to be approximately 115% of net income. Total debt was $1.67 billion at March 31, down slightly from the 2014 year end. Offsetting this debt is cash and cash equivalents of $407 million, resulting in a net debt-to-capital ratio in March 31 of 27.9%.

At March 31, we had approximately $1.2 billion of cash and existing credit facilities to fund our growth initiatives. Our highest priority for capital deployment remains acquisitions. In summary, we had a very good first quarter, and we are well positioned for 2015.

Our ample financing capability and strong cash flows will continue to support our growth investments both organically and through acquisitions..

Great. Thank you, Bob. Susie, we're now happy to open it up for questions..

Thank you. Our first question coming from the line of Allison Poliniak with Wells Fargo. Please proceed with your question..

Hi, guys. Good morning..

Hi, Allison..

So we've been hearing a lot the past two weeks about sort of this pervasiveness of this oil and gas decline and sort of the tentacles reaching out into the industrial U.S. And obviously, you talked about the export impact, just given the foreign currency headwind.

I mean what's the greatest impact in your mind to AMETEK right now? And I mean I guess based on your limited visibility, what can you see as we move to 2015 here?.

Yeah. Well in terms of oil and gas, we had given you an estimate at the beginning of the year that we thought we were going to be impacted about $40 million in our overall sales as a result of the oil and gas downturn. And in fact, that estimate is holding. That's roughly what we're seeing from the oil and gas downturn.

The effect is obviously significant on the upstream part of our business, but it's offset by really better performance or good performance in the midstream and downstream sector. Interesting, this morning that BP and Total introduced their earnings and their oil and gas businesses were down sizably but less than what estimates analysts had expected.

And the reason was the same thing, that their midstream and downstream businesses were very strong. So I think we're paralleling the market, and it shows the diversification of AMETEK's portfolio where any single part of the portfolio, when it goes in decline, is not going to have that significant an impact on the overall business.

So that's how I would characterize the Oil & Gas segment for us..

Okay. And then just on investment growth in this environment, it seems like you pulled your RD&E down a little bit.

Any others that you feel that you need to pull down near term, just given sort of the uncertainty?.

Yeah. Actually, it's a great question on RD&E because in essence, you're right that we had given a little bit higher number. But it's actually the result of the translation because of the change in currency. So the actual amount of activity worldwide in the company in terms of people working in the RD&E environment has not been substantially impacted.

And we have been very selective in our realignments, as I mentioned in my opening remarks, not to impact our long-term growth. So that question is a great one. If you look at the realignment that we did, we focused it on the operating side of the company.

I mean our factories and those parts of the business that will be impacted by a bit of a slower growth environment than what we had originally intended. So we have done some employment reductions. We have done some belt tightening.

We have done some and will be doing some additional facility consolidations, but again, very selective not to impact our overall growth..

Great. Thanks so much..

Okay, Allison..

Thank you. Our next question coming from the line of Nigel Coe with Morgan Stanley. Please proceed with your question..

Hi. Good morning. It's actually Mike signing in for Nigel..

Hello..

Had a quick question on the restructuring that you guys....

Yes..

The realignment that you guys announced.

So could you give us a sense on how that phases through the year? So the $40 million that you alluded to, Frank, how much of that came in 1Q and how much of that do you expect in 2Q?.

Virtually, none in the first quarter and fairly evenly split through the year. A little bit lighter in the second quarter but definitely gaining full steam in the third and the fourth quarters of this year..

Okay. Great. And just to piggyback a little bit on Allison's question. She mentioned pressure that's pervasive and export demand of the U.S. Is that something that you're seeing accelerate through the quarter? And if you can quantify that, that'd be great..

Yeah. I wouldn't say accelerate through the quarter. When you look at the European economy in particular, with the dramatic change in the euro, obviously, anything that you are exporting into that environment is going to be less competitive with respect to local suppliers than it was.

We're very fortunate in that our portfolio is extremely differentiated and we have not had to make significant concessions. But there's no question that the competitive issue does have an impact. It's just impossible to quantify.

And I noticed that many other companies are not even talking about it, but I would clearly say it's having an impact on us but it's not that significant..

Awesome. Thank you..

Sure..

Thank you. Our next question, coming from the line of Christopher Glynn with Oppenheimer. Please proceed with your question..

Thanks. Good morning, everybody..

Good morning, Chris..

Good morning. So I was just wondering if you could describe the linearity through the quarter and into April..

Yeah. Actually, when you look at the linearity, it actually improved during the quarter. Looking at order input, order input did go up as we went through the quarter. So we feel relatively good about that.

But still, when you consider the global macros, that's why we decided to take a very conservative view on organic growth for the year and why we decided to do the realignment that I've talked about..

Okay. And it sounds like the improvement was sort of gentle rather than a horrific January and a killer March, so to speak..

Yeah. I think that's fair. I'd love to use the word killer but it's not appropriate..

Right.

And any surprising divergences among end markets or geographies?.

No. I would say there's not amazing change. It's just that when you look outside the United States, you look in Europe, obviously, that economy remains weak. Asia is still good but it's not as good as it has been. And that's being offset by a stronger U.S. economy.

Our organic growth was actually up nicely in the United States, so the issues we're seeing are largely offshore and largely focused in really Asia and Europe..

Okay. And then just on the restructuring, a couple angles I wanted to ask about. One, as we move into the year is the thought that the restructuring payback sort of takes the baton from belt tightening in the earlier part of the year.

And then the second one would be, given all the acquisitions you've done over the past several years, is there maybe an opportunity to take a larger realignment position this year?.

Yeah. No, I don't feel the necessity to do any larger realignments. With that we've done, I've got significant confidence in the earnings and the guidance that we provided to you.

So I feel we've taken a conservative view of the top line, and that has led to this restructuring and that something would have to radically change in the global environment in order for us to be required to do more. In terms of opportunity, absolutely.

There is significant opportunity that we see, given the global environment, so you might just as well take advantage of it. We are looking at a number of acquisitions. Several of them have high European content, and you just take advantage of the global situations as they develop.

And we're not going to change our strategy at all in terms of continuing a focus on the international environments. It's just that they're a bit weak right now, but that will change over time..

Great. Sounds pretty good, Frank. Thank you..

You bet..

Thank you. Our next question, coming from the line of Matt McConnell with RBC. Please proceed with your question..

Thank you. Good morning, guys..

Hello, Matt..

So the commentary about the strength across geographies was definitely helpful. I wonder if you could do something similar about end markets because I know the organic revenue outlook isn't down dramatically, but you're towards the low end of the range. And it sounds like oil and gas maybe might not be the culprit there.

So anything you can point to on the end market side that has organic growth coming in kind of towards the low end?.

Yeah. I mean if you look across our businesses and take a look at EIG, for instance, our Aerospace and Power and Industrial businesses performed very well in the quarter. But our Process businesses were the ones that weakened and what caused us to take a more conservative view on the organic growth.

And obviously, the oil and gas impact that I talked about is in that Process segment. But in addition, when we look at the weakened U.S. economy – or excuse me – Europe economy and the weakened or slowing Asia economy, that has, across our businesses, the most significant effect on our Process businesses.

So that was the key factor in why our organic growth in the EIG part of the business was a bit down from where we thought it was going to be at the end of the first quarter.

So I think if you focus on the Process businesses, you focus on the global part of the Process businesses because a major part of those businesses in terms of percentage is higher than our other businesses outside the U.S. That is a predominant area in the company that took the impact..

Okay. Great. Thanks. That's helpful. And switching gears a little bit to the M&A pipeline, it's been a few quarters since the deal and I know it's always lumpy. You have plenty of balance sheet capacity, obviously.

Anything on just seller expectations or the marketplace or what you're able to uncover? Just any update on what you're seeing on the M&A space would be helpful. Thanks..

Yeah. No, I see our strategy of continuing to do acquisitions, as Bob and I both mentioned, our opening remarks, is the prime use of our cash flow. And I'm quite optimistic about being able to do additional deals and deploy a significant amount of capital in this fiscal year. I can tell you we're actively working on deals as we speak.

It's hard to predict when and if a deal is going to close, but I would be surprised if you didn't hear from us throughout the year..

Okay. It sounds good. Thank you very much..

You bet..

Thank you. Our next question, coming from the line of Robert McCarthy with Stifel. Please proceed with your question..

Good morning, everyone.

How's everybody doing?.

Good. Hi, Rob..

Fine. Thanks, Rob..

Good, good, good. So I guess on the M&A question, maybe to come at it from a slightly different direction. Part of the problem on the opportunity for you on the M&A front is presumably, you're looking at the properties that have a lot of European exposure and then also probably a lot implied petrochem exposure.

Maybe not directly, but there's going to be a sizeable part of their end markets that are going to serve those end markets or those businesses.

So how does that kind of inform your – the bid ask around what you're trying to do in terms of acquiring some of these companies? Because clearly, even if you think your own core oil and gas exposure's manageable, in terms of the rhetoric, in terms of getting deals on the goal line, you're going to be fairly adamant about giving companies with oil and gas exposure a bit of a haircut in terms of the valuation.

How do you see that playing out in terms of your opportunity set and your ability to close on some of these properties?.

Yeah. I mean if you specifically take the question on oil and gas, again, as I mentioned, the oil and gas exposure for AMETEK is not that significant. And so when we look at our portfolio of deals, many of the deals we're looking at do not have oil and gas exposure.

Having said that, I view it as an opportunity with companies that have oil and gas exposure. And that we're going to pay a multiple based on their earnings and the expectations that we see, and we're very good at actually putting cycles in our models.

We don't assume wherever a business is that that's going to be exactly what's going to happen in the future. So in oil and gas, we value these, take into account their cyclicality.

And some companies need to sell, so they're going to sell at a point that maybe isn't desirable for them, since the pricing could be a bit lower, but obviously is an opportunity for us. So I'm not shy about doing an acquisition in oil and gas. You just have be clear in terms of what the projected earnings of that company is going to be.

But I would say, just to reiterate, looking at our portfolio of acquisitions and some of the ones we're working on now, one of them, there's no oil and gas exposure. The other one, there's a little bit. So that's maybe the best way that I can characterize your question..

Yeah. I mean to be clear, just to close the loop here, I think you would argue with my premise that a lot of your M&A pipeline is tied to oil and gas-related properties..

Exactly..

Okay. All right. Fair enough. And then in terms of the restructuring, I mean you've given a lot of detail around kind of the benefits you expect to see.

Have you talked specifically about a payback in association with the restructuring? And maybe you could just give a little bit of complexion around maybe the cash, non-cash in association with it and where you're spending on in terms of logistics, procurement or plant or people.

How should we think about some of the complexion in the restructuring?.

Yeah. I mean you look at the amount of cost that we're taking, it's basically $16 million in one-time cost, which is roughly $0.04 a share. And as I said, the annualized benefit from this is $55 million.

So you look at the payback and it is extremely good, and that's because of the type of realignment – I really don't want to use the word restructuring because this isn't what I would call a major restructuring. It's a realignment. The return on this investment is absolutely incredible, and we just felt it was necessary to do.

In terms of your question on cash versus non-cash, Bob, can you answer that?.

Yeah. Essentially, the entire $15.9 million is cash. There's a little bit of non-cash in there. But again, this was focused on reduction in force as well as the kinds of operating opportunities that we can get cost out of the business. So it's not in the context of asset breakdown.

This is true cost potentially that we're going to see immediately, and that's why you see the payback showing up so quickly..

Great. Well, I guess I'll see you guys soon enough. And good luck with the rest of the day..

Yes. Okay. Thank you..

Thank you. Our next question, coming from the line of Scott Graham with Jefferies. Please proceed with your question..

Hey, good morning..

Hello, Scott..

Hey. So I wanted to – and Bob gave me some of the answers to the questions I was looking for the RIFs (35:02) and the operating cost focus. Could you talk about which businesses these are maybe more focused on? Because this realignment is not typical AMETEK. It's a little bit different than we've seen for quite some time.

I'd go back, I think, to the last downturn. Maybe tell us, Frank, kind of how you're thinking of this, how you conceived it because it is a little bit different than what you usually do.

What business is most affected? And importantly, does this hurt the prospect of that $100 million productivity in out years from here?.

Okay. Scott, yeah. I mean I think what I will say is that when we looked at all of the macro environment issues that are going on right now that most companies are reporting, most companies took down their guidance. And I look at this that when I give a guidance range, there is a commitment from us to make those estimates.

And that's really embodied in the culture and the approach that AMETEK has taken for many, many years. So as we saw the growth prospects coming down by a few points, we just didn't wait around. We're going to take actions and we're going to realign.

And I can sit here and with confidence tell that our earnings are going to occur within the range that I talked about and hopefully above that range. So I mean that's sort of the top line premise. We looked at our businesses in light of where we were seeing the change in organic growth from our initial estimates.

And obviously, we've already talked about the Process businesses. So we took some actions there. We took some actions in EMG.

But the way we looked at it is, where are the businesses that are looking at a lower growth than what they originally had talked about? So your comment about this is different, I guess from the viewpoint that we haven't done it since 2008 or 2009, it's probably correct.

But if you look at the Zygo acquisition we did and are doing a lot of realignment there. And if you go back in history, we just have a very strong commitment to making the earnings numbers. And when we see an issue, we deal with it. And you just don't let the issue get behind you, in essence; you get in front of it.

And that's what we did, and so I hope that helps with your question..

It does, indeed. The simple follow-up I would have is, I guess, is not so simple is if you can kind of do your thing, Frank, with the businesses and kind of how the sales rolled out and expectations roll out from here..

Yeah. Sure. I'd be glad to do that. So if we start with EIG in Aerospace, EIG, Aerospace had a very good first quarter with organic sales up mid single digits, reflecting strong growth in our regional and business jet business and the continued solid growth in our commercial OEM business.

Organic orders were also very strong in the quarter, up low double digits. And we're very pleased with the continued strong performance in EIG, Aerospace.

This business is well-positioned to continue to drive strong growth, given key wins on a number of next-generation commercial aircraft, including the A350, the 787 and the C919 as well as a number of business and regional jet platforms including HondaJet, Global Express and Agusta.

For all of 2015, we expect EIG, Aerospace sales to be up mid single digits, driven by the continued ramp-up of these key commercial OEM platforms and solid growth in business and regional jets. We've already talked a bit about our Process businesses. Organic sales in the Process businesses were down low single digits in the quarter.

That was against a difficult prior-year comparison. In 2015, we expect organic sales to be up low single digits over 2014. And as I've mentioned, we've reduced our full-year growth estimates for the Process businesses as a result of the impacts of the stronger U.S. dollar and a slow global macro environment.

Power and Industrial had a good first quarter. Organic sales were up mid single digits with solid growth across both our Power and Industrial businesses. And for 2015, we expect organic sales for Power and Industrial to be up low-single digits.

So if you look at all of EIG then, we expect organic sales for the year to be up low single digits on a percentage basis. Scott, moving to the other part of AMETEK, EMG, our differentiated EMG businesses had a good first quarter.

Organic sales were up low single digits, driven by solid growth in our Precision Motion Control and Engineered Materials, Interconnect and Packaging businesses. And for 2015, we expect our differentiated EMG businesses to be up low single digits organically. And last part of our company, our legacy businesses, Floorcare and Specialty Motors.

Organic sales in our Floorcare and Specialty Motors businesses were flat in the first quarter. For all of 2015, we expect this business to be up low single digits organically. And I'd like to mention that the management team, in particular, in Floorcare and Specialty Motors, is really doing an excellent job in this business.

So if you sum those two parts of EMG, Scott, for all of 2015 for EMG, we expect organic growth of low single digits on a percentage basis. And then lastly, if you take EIG and EMG, as I mentioned in my opening comments, for all of AMETEK, we expect low single-digit organic growth for the year conservatively, I would say..

Frank, thank you..

You bet..

Thank you. Our next question, coming from the line of Joe Radigan with KeyBanc. Please proceed with your question..

Thank you. Good morning, guys..

Good morning, Joe..

In terms of the second quarter revenue guidance, flat overall, how does that break out by segment on an organic basis, Frank?.

Yeah. It's going to be roughly the same for each of the segments in the second quarter. I don't see a significant difference between the two segments..

Okay. And then the margins in EMG, I mean record performance there.

Is that how we should think about that segment going forward and in the second quarter, kind of assuming the revenue growth environment? Or was there some favorable mix there or some other dynamic that doesn't necessarily repeat?.

Yeah. I'll let Dave take that question..

Yeah. I don't think it's a mix issue that won't repeat. There's been really strong cost management in EMG, and the margins that you see are more indicative of the future. So we expect to expand margins in EMG more so than EIG, but it will continue..

Okay..

And just to expand, Joe. I think if you look at all of AMETEK now, we're going to see really superb margin performance this year. We're going to be year-over-year, I would say, well above 100 basis points of operating income margin improvement.

So Dave and his team have done just a phenomenal job on the performance of both of these businesses, both EIG and EMG. And the margin performance is truly superb..

Okay. And then lastly for me, I mean you mentioned China organically, your revenue was up mid-teens. But you also talked about the, obviously, the slowing economy there.

So – and you touched on this a little bit in your prepared comments, but can you talk more about what's driving that? Is it just the growth initiatives that you're instituting there? And what's your outlook for China going forward for this year and beyond?.

Yeah. Okay. It's a great question. If you look at the first quarter, there was a bit of an anomaly in our results in that when you look at last year, we had huge benefits from Abenomics in Japan. So therefore, the results in China, which were very good, were offset by the results in Japan, in essence.

And we still consider the Far East and in particular, China, very good regions of the world in terms of investment. We are not changing our investment strategy at all. We're going to continue to put manufacturing capability and sales and service capability in that part of the world.

The difference is that this – we were reporting overall for Asia growth numbers that were extremely high for the last couple years and now they're going to be more modest. You look at the GDP in China. It, at points, was running 10%, 11%. Now they're forecasting 7%. So you compare that 7% GDP with the U.S.

and Europe, it's still the fastest-growing part of the world but it's not growing at the same rate. And that's the way that we are viewing that part of the world. It's still a great place to invest, but it's not growing at the rates that it was..

Okay. Great. Thanks, Frank. Thanks, Dave..

Sure..

Thank you. Our next question, coming from the line of Mark Douglass with Longbow Research. Please proceed with your question..

Good morning, gentlemen..

Hi, Mark..

Hello, Mark..

Bob, what were payables in the quarter?.

$381 million..

$381 million. Thank you.

What were orders in backlog?.

Orders were $944 million. They were overall down 5.5%. Organically, they were actually up low single digits. And the currency impact here was huge. It was 8%. And the reason is that you obviously have to readjust the backlog as the currencies have so dramatically changed.

If you look at the total backlog, it's now $1.2 billion, essentially flat with where it was at the beginning of the year..

How much of that backlog was due to currency?.

8%. I mean, well the backlog. That's a different....

Percent of backlog?.

Yeah. You have to do 8% of $1.2 billion. No. No. The U.S. part of – it was not all of it. But why not, instead of us guessing here, why don't we get to that answer? It's 8% of the part of the backlog that obviously is international, and we don't have that right here at our fingertips..

Okay. You can follow up. And then, Frank, on the realignment spending $16 million and getting $55 million in annualized benefits is pretty huge. It's a hard number to fathom on $16 million of spend.

I guess it begs the question, why wouldn't you have done it sooner if the returns are this strong?.

You're always – that's a great question. And first of all, the return is as good as it is, predominantly because it is related to severance cost. And therefore, the return, as Bob said, is immediate and it's quick. And you get an excellent return on that.

And in terms of your other question, basically, as you know, every year, we try to balance the cost reductions with other things that we are doing. We always have a large number. If you look historically over the last few years, we talked about $100 million of improvements. And again, as we saw the macro situation, we decided to get more aggressive.

We always have a list of things that we can do, and we balance that based on the environment. And in this case, as we saw the slowing sales, as just about every industrial company is seeing, we recognized that we weren't going to be shipping as much from our operating facilities. So therefore, we took action.

I mean it's pretty straightforward and pretty simple. If we were going to be shipping at a higher level, then we wouldn't have done it..

Right, right. Even with that lower guidance, it's still a pretty big number and you already run pretty lean. So it's just surprising that you're able to find so much. So – but that's a good number..

We're good at this..

All right. Thanks for taking my questions..

Thank you. Our next question, coming from the line of Richard Eastman with Robert W. Baird. Please proceed with your question..

Yes. A couple things. Frank, the reduction in the core growth for 2015 in the EMG business, kind of comes in that technical motor space. It looks like the cost-driven business is kind of intact in terms of what their expectation was.

Is the technical motors piece, is that being influenced by that $100 million of revenue that is kind of sprinkled throughout technical motors from the energy business? Is that where you'd be able to identify some softness there?.

Yeah. No question, Rick. If you look at those businesses in the differentiated part of EMG, they also have global market exposure. And what we're seeing is as those economies are weaker, Europe, weak; Asia, not quite as strong as it was, there's an impact there as well. So, yes, we have indeed looked at our thoughts around that differentiated segment.

And it's also lower by a couple of points..

And just to back up a little bit, there was a reference earlier about exports. And obviously, I think most appreciate the competitiveness or lack of when the dollar strengthens like it has..

Right..

But can I ask you, I mean what percentage of your sales are exports from U.S. to Europe? And then secondly, is there a price component there? Or is it – again, your products are so differentiated, I can't imagine that switching costs aren't awfully high.

So do you have to price more competitively there just because of the strength of the dollar?.

In general, not, I would say, in terms of the pricing impact. We have made, in some of our – I would call it less differentiated products, we have made some minor adjustments in pricing. But in general, the differentiated part of our portfolio is definitely strong enough that we don't have to do substantial reductions in price.

Now having said that, you look at Europe, the economy is not good. It's the weakest of the three general, major economies in the world. And it's impossible to distinguish between whether or not they're – what the impact of the competitiveness issue is from the fact that it's just a slowing economy. So we can't put a number on it.

I don't think anybody can really put a number on it. So – but to say it's not there would be naïve. So we know there is some of that. I don't think it's substantial. And we're really talking about a couple points change here. It's not like we're talking about a 10% change..

Yeah.

And just price capture overall in the first quarter?.

Yeah, it's good question. It was 1.5% price capture. And when we rolled up all inflation cost to our best ability – it's not a perfect roll-up. But if you take that roll-up and you look at price minus inflation, it's about 0.6%. So we continue to get good pricing and we continue to bring it to the bottom line at a rate higher than inflation.

And that's a key thing that we look at and manage..

Okay. And just one last question. Was Zygo's revenue in the quarter where you expected or at plan? The total acquisition contribution looks somewhat light to us.

Maybe could you just address that?.

Yeah. Rick, you can't really peanut butter the revenue across quarters. It's a lumpy business and it met our expectation for the first quarter..

Okay. Okay. Thank you..

Thank you. Mr. Coleman, there are no further questions at this time. I will now turn the call back to you. Please continue with your presentation or closing remarks..

Thank you, Susie. Thanks, everyone, for joining our call today. As a reminder, a replay of the call can be accessed to ametek.com and streetevents.com. And as always, I'm available for further questions today. Thanks again..

Ladies and gentlemen, that does conclude the conference call for today. We thank you for your participation and ask that you please disconnect your lines. Have a great day..